Chennai, 26 March 2012; Using the immune cells of the patient herself, recurrent ovarian cancer with metastases has been treated and a prolonged survival for18 months with decrease in size of the cancer has been published in the “Case reports in oncology” journal. This methodology called as AIET (Autologous Immune Enhancement Therapy; www.immunotreatment.org) which has been in clinical practice in Japan for more than two decades, has been accomplished by two Chennai based institutes Nichi-In Centre for Regenerative Medicine (NCRM), and Cancer Relief and Research Trust (CRRT), using proven Japanese technologies.
The prognosis of an Ovarian cancer which has recurred with metastases is very poor. But in this case, the combination of autologous immune enhancement therapy with other modalities might have helped with reduction in size of the cancer metastatases and improved the quality of life and prolonged survival said Dr Ramanan of CRRT, one of the co-authors of the paper.
Natural Killer(NK) cells, that continuously do the surveillance for cancer cells and viruses and curtail any cancer in the bud. These NK cells are taken from the patient’s blood and multiplied in the laboratory manifolds and re-injected to destroy the cancer cells and the technology for multiplication of NK cells using patient’s own serum was developed by Dr.Hiroshi Terunuma of Biotherapy Institute of Japan, Tokyo, a co-author of the publication.
* The full article is available online at: http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowPDF&ArtikelNr=337319&